Back to Agenda
Round Table Luncheon Discussions
Session Chair(s)
Round Table Discussions
, United States
There will be a 30 minute session for a limited number of participants to join roundtable discussions during the lunch break. Key thought leaders will help facilitate the discussions.
Speaker(s)
Michelle Bulliard, BSN
Vice President, Global Head Real-World Evidence Strategy Unit, IQVIA, Switzerland
Keith K. Burkhart, MD
Senior Advisor for Medical Toxicology, DARS, OCP, OTS, FDA, United States
Marsha Millikan, RPH
Advisor, Expedited Reporting Global Patient Safety, Eli Lilly and Company, United States
Elizabeth E. Garrard, PHARMD
Executive Vice President, Global Safety Operations , Clinipace Worldwide, United States
Saad Shakir, MD, FFPM, FISPE, FRCP
Pharmacovigilance Physician and Pharmacoepidemiologist, ADROITVIGILANCE, United Kingdom
James A. Seaton
Executive Consultant, Seaton Associates, LLC, United States
Mariette Boerstoel-Streefland, MD, MBA, MS
Senior Vice President, Patient Safety Officer , Bristol Myers Squibb, United States
Have an account?